Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV
Clinical trial NCT02293317 · COMPLETED
Trial details
- NCT number
- NCT02293317
- Sponsor
- BiondVax Pharmaceuticals ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.